XenoNet: Inference and Likelihood of Intermediate Metabolite Formation
- PMID: 32525671
- PMCID: PMC8716322
- DOI: 10.1021/acs.jcim.0c00361
XenoNet: Inference and Likelihood of Intermediate Metabolite Formation
Abstract
Drug metabolism is a common cause of adverse drug reactions. Drug molecules can be metabolized into reactive metabolites, which can conjugate to biomolecules, like protein and DNA, in a process termed bioactivation. To mitigate adverse reactions caused by bioactivation, both experimental and computational screening assays are utilized. Experimental assays for assessing the formation of reactive metabolites are low throughput and expensive to perform, so they are often reserved until later stages of the drug development pipeline when the drug candidate pools are already significantly narrowed. In contrast, computational methods are high throughput and cheap to perform to screen thousands to millions of compounds for potentially toxic molecules during the early stages of the drug development pipeline. Commonly used computational methods focus on detecting and structurally characterizing reactive metabolite-biomolecule adducts or predicting sites on a drug molecule that are liable to form reactive metabolites. However, such methods are often only concerned with the structure of the initial drug molecule or of the adduct formed when a biomolecule conjugates to a reactive metabolite. Thus, these methods are likely to miss intermediate metabolites that may lead to subsequent reactive metabolite formation. To address these shortcomings, we create XenoNet, a metabolic network predictor, that can take a pair of a substrate and a target product as input and (1) enumerate pathways, or sequences of intermediate metabolite structures, between the pair, and (2) compute the likelihood of those pathways and intermediate metabolites. We validate XenoNet on a large, chemically diverse data set of 17 054 metabolic networks built from a literature-derived reaction database. Each metabolic network has a defined substrate molecule that has been experimentally observed to undergo metabolism into a defined product metabolite. XenoNet can predict experimentally observed pathways and intermediate metabolites linking the input substrate and product pair with a recall of 88 and 46%, respectively. Using likelihood scoring, XenoNet also achieves a top-one pathway and intermediate metabolite accuracy of 93.6 and 51.9%, respectively. We further validate XenoNet against prior methods for metabolite prediction. XenoNet significantly outperforms all prior methods across multiple metrics. XenoNet is available at https://swami.wustl.edu/xenonet.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
Similar articles
-
Message Passing Neural Networks Improve Prediction of Metabolite Authenticity.J Chem Inf Model. 2023 Mar 27;63(6):1675-1694. doi: 10.1021/acs.jcim.2c01383. Epub 2023 Mar 16. J Chem Inf Model. 2023. PMID: 36926871 Free PMC article.
-
Modeling the Bioactivation and Subsequent Reactivity of Drugs.Chem Res Toxicol. 2021 Feb 15;34(2):584-600. doi: 10.1021/acs.chemrestox.0c00417. Epub 2021 Jan 26. Chem Res Toxicol. 2021. PMID: 33496184 Free PMC article.
-
Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.J Chem Inf Model. 2020 Oct 26;60(10):4702-4716. doi: 10.1021/acs.jcim.0c00360. Epub 2020 Sep 16. J Chem Inf Model. 2020. PMID: 32881497 Free PMC article.
-
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
-
Detecting reactive drug metabolites for reducing the potential for drug toxicity.Expert Opin Drug Metab Toxicol. 2015;11(8):1281-302. doi: 10.1517/17425255.2015.1048222. Epub 2015 May 25. Expert Opin Drug Metab Toxicol. 2015. PMID: 26005795 Review.
Cited by
-
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.Metabolites. 2021 Jun 15;11(6):390. doi: 10.3390/metabo11060390. Metabolites. 2021. PMID: 34203690 Free PMC article.
-
NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism.Elife. 2021 Aug 3;10:e65543. doi: 10.7554/eLife.65543. Elife. 2021. PMID: 34340747 Free PMC article.
-
MetaClass, a Comprehensive Classification System for Predicting the Occurrence of Metabolic Reactions Based on the MetaQSAR Database.Molecules. 2021 Sep 27;26(19):5857. doi: 10.3390/molecules26195857. Molecules. 2021. PMID: 34641400 Free PMC article.
-
Message Passing Neural Networks Improve Prediction of Metabolite Authenticity.J Chem Inf Model. 2023 Mar 27;63(6):1675-1694. doi: 10.1021/acs.jcim.2c01383. Epub 2023 Mar 16. J Chem Inf Model. 2023. PMID: 36926871 Free PMC article.
-
Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics.Drug Metab Dispos. 2021 Feb;49(2):133-141. doi: 10.1124/dmd.120.000254. Epub 2020 Nov 25. Drug Metab Dispos. 2021. PMID: 33239334 Free PMC article.
References
-
- Kalgutkar AS; Didiuk MT Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity. Chem. Biodiversity 2009, 6, 2115–2137. - PubMed
-
- Ostapowicz G; Fontana RJ; Schiødt FV; Larson A; Davern TJ; Han SH; McCashland TM; Shakil AO; Hay JE; Hynan L; Crippin JS; Blei AT; Samuel G; Reisch J; Lee WM Results of a prospective study of acute liver failure at 17 tertiary care centers in the united states. Ann. Intern. Med 2002, 137, 947–954. - PubMed
-
- Srivastava A; Maggs J; Antoine D; Williams D; Smith D; Park B Adverse Drug Reactions; Springer, 2010; pp 165–194.
-
- Watkins PB; Seeff LB Drug-Induced Liver Injury: Summary of a Single Topic Clinical Research Conference. Hepatology 2006, 43, 618–631. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
